The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
The global burden of chronic urticaria for the patient and society*
Abstract
Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and middle‐aged women. It usually lasts for several years (> 1 year in 25–75% of patients) and often takes > 1 year before effective management is implemented. It presents as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) or both in the same person. More than 25% of cases are resistant to H1‐antihistamines, even at higher doses, and third‐ and fourth‐line therapies (omalizumab and ciclosporin) control the disease only in two‐thirds of H1‐antihistamine‐resistant patients. Here we review the impact of CU on different aspects of patients’ quality of life and the burden of this chronic disease for the patient and society. CU may have a strong impact on health‐related quality of life (HRQoL), particularly when CSU is associated with angio‐oedema and/or CIndU (Dermatology Life Quality Index > 10 in 30% of patients). Comorbidities, such as anxiety and depression, which are present in more than 30% of patients with CSU, compound HRQoL impairment. Severe pruritus and the unpredictable occurrence of weals and angio‐oedema are responsible for sleep disorders; sexual dysfunction; limitations on daily life, work and sports activities; interfering with life within the family and in society; and patients’ performance at school and work (6% absenteeism and 25% presenteeism). Apart from treatment costs, with annual values between 900 and 2400 purchasing power parity dollars (PPP$) in Europe and the USA, CU is associated with a high consumption of medical resources and other indirect costs, which may reach a total annual cost of PPP$ 15 550.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A. H., Baker, D., Ballmer‐Weber, B., Bernstein, J. A., Bindslev‐Jensen, C., Brzoza, Z., Buense Bedrikow, R., et al. (2018) · Allergy · doi:10.1111/all.13397 · Cited by 1,445
Self-citationZuberbier, T., Aberer, W., Asero, R., Bindslev‐Jensen, C., Brzoza, Z., Canonica, G. W., Church, M. K., Ensina, L. F., Giménez‐Arnau, A., Godse, K., et al. (2014) · Allergy · doi:10.1111/all.12313 · Cited by 1,203
Self-citationOmalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Maurer, M., Rosén, K., Hsieh, H.-J., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215372 · Cited by 1,105
Self-citationMaurer, M., Weller, K., Bindslev-Jensen, C., Giménez-Arnau, A., Bousquet, P. J., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E. H., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02496.x · Cited by 843
Self-citation10 Years Experience of the Dermatology Life Quality Index (DLQI)
Lewis, V., & Finlay, A. Y. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.09113.x · Cited by 479
Saini, S. S., Bindslev-Jensen, C., Maurer, M., Grob, J.-J., Bülbül Baskan, E., Bradley, M. S., Canvin, J., Rahmaoui, A., Georgiou, P., Alpan, O., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.306 · Cited by 471
Self-citationFricke, J., Ávila, G., Keller, T., Weller, K., Lau, S., Maurer, M., Zuberbier, T., & Keil, T. (2020) · Allergy · doi:10.1111/all.14037 · Cited by 465
Self-citationThe impact of chronic urticaria on the quality of life
O'DONNELL, B. F., LAWLOR, F., SIMPSON, J., MORGAN, M., & GREAVES, M. W. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb14895.x · Cited by 465
Weller, K., Groffik, A., Church, M. K., Hawro, T., Krause, K., Metz, M., Martus, P., Casale, T. B., Staubach, P., & Maurer, M. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1076 · Cited by 417
Self-citationPsychiatric morbidity in dermatological outpatients: an issue to be recognized
Picardi, A., Abeni, D., Melchi, C. F., Puddu, P., & Pasquini, P. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03831.x · Cited by 413
Cited by
Zuberbier, T., Abdul Latiff, A. H., Abuzakouk, M., Aquilina, S., Asero, R., Baker, D., Ballmer‐Weber, B., Bangert, C., Ben‐Shoshan, M., Bernstein, J. A., et al. (2022) · Allergy · doi:10.1111/all.15090 · Cited by 1,263
Self-citationKolkhir, P., Giménez-Arnau, A. M., Kulthanan, K., Peter, J., Metz, M., & Maurer, M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00389-z · Cited by 382
Self-citationNeisinger, S., Sousa Pinto, B., Ramanauskaite, A., Bousquet, J., Weller, K., Metz, M., Magerl, M., Kocatürk, E., Cherrez‐Ojeda, I., Gimenez‐Arnau, A. M., et al. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12328 · Cited by 37
Self-citationThe role of the environment in allergic skin disease
Faraz, K., Seely, M., & Marano, A. L. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-024-01147-9 · Cited by 20
Nie, Y., Liu, L., Xue, S., Yan, L., Ma, N., Liu, X., Liu, R., Wang, X., Wang, Y., Zhang, X., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22901-4 · Cited by 15
Metadata
- Authors
- Gonçalo, M., Gimenéz‐Arnau, A., Al‐Ahmad, M., Ben‐Shoshan, M., Bernstein, J. A., Ensina, L. F., Fomina, D., Galvàn, C. A., Godse, K., Grattan, C., Hide, M., Katelaris, C. H., Khoshkhui, M., Kocatürk, E., Kulthanan, K., Medina, I., Nasr, I., Peter, J., Staubach, P., Wang, L., Weller, K., & Maurer, M.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-02
- Volume
- 184
- Issue
- 2
- Pages
- 226-236
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W3087522660
- Cited by
- 357
- References
- 114
- FWCI
- 23.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The global burden of chronic urticaria for the patient and society*. https://app.cochat.ai/papers/10.1111/bjd.19561
- The paper
- Gonçalo, M., Gimenéz‐Arnau, A., Al‐Ahmad, M., Ben‐Shoshan, M., Bernstein, J. A., Ensina, L. F., Fomina, D., Galvàn, C. A., Godse, K., Grattan, C., Hide, M., Katelaris, C. H., Khoshkhui, M., Kocatürk, E., Kulthanan, K., Medina, I., Nasr, I., Peter, J., Staubach, P., . . . Maurer, M. (2021). The global burden of chronic urticaria for the patient and society*. British Journal of Dermatology. https://doi.org/10.1111/bjd.19561
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.